"We know definitively that we can prevent almost all bleeding – decreasing bleeding frequency by > 90% as well as the severity of bleeding episodes – by continuing prophylaxis into adulthood or ...
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression. The FDA has approved the antiviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback